One draft order, two outlets, and almost nothing checkable yet
The White House is drafting an executive order that would create an external committee with veto power over NIH grants, according to the New York Times. That is the entirety of what two outlets have established. The story is real — Bhattacharya and Vought are named, billions in research spending are in scope — but the coverage is still at the stage where the document hasn't landed and the details are sparse enough that framing analysis has little to grip.
White House moves to take control of NIH grants
2 sources · hover a dot to see coverage
What happened
The New York Times reported on September 20, 2026, that White House officials are drafting an executive order that would subject NIH grants to review by an outside panel. The order, reportedly directed by the Trump administration through budget director Russell Vought, is designed to give the administration authority to block awards that don't align with its policy priorities. NIH director Jay Bhattacharya is named as involved. The mechanism would be an external committee with effective veto power over grant decisions, redirecting what the Times describes as billions of dollars in research spending. SAN reported the same story, attributing it to the Times. No text of the draft order has been published, no committee members have been named, and no timeline for the order's signing has been reported. That is the wire version. Two outlets have it, and both are working from the same sourcing.
What one side told you that the other didn't
Both outlets are citing the same source. Neither has the document.
SAN's coverage is a rewrite of the Times report, attributed explicitly to the Times. That means this story rests on a single outlet's sourcing. No draft text has been published, no committee members named, no signing timeline confirmed. A policy that would give political appointees veto power over peer-reviewed grant awards is significant enough that its confirmation should not depend on one newsroom's anonymous federal officials. Until a second independent outlet confirms the order's contents, the story is a leak, not a fact.
The veto mechanism is the story. Neither outlet has explained it.
The Times says an 'outside panel' would review grants. Neither outlet names who would sit on that panel, how members would be selected, what criteria they would apply, or whether existing grantees would be subject to review. 'External committee with veto power' covers a wide range of possibilities, from a modest advisory board to a political clearinghouse for all federal biomedical research. The difference matters enormously for the $47 billion NIH budget, and right now the coverage doesn't distinguish between them.
What to watch
If the executive order is signed or its text is published within the next two weeks, watch whether right-leaning outlets frame the panel as accountability reform while left-leaning outlets frame it as political interference in peer review. The specific trigger to watch: whether any named scientist or university research office publicly refuses compliance, which would force outlets that have downplayed the story to catch up fast.
See how outlets across the political spectrum framed this differently — and what each side left out.